(Date:1/8/2009)... - GEOLOGY topics include "the best submarine re...lack Sea, hazardous volcanic ice-slurry flows, the... cracks in the Atacama Desert, CO 2 sequestration...field and the cosmic-ray-climate theory, fresh-wat...ls preserved in French amber, tiny fossil fish tee...
(Date:1/8/2009)...ailable in German . ,, The nuclei of ord... If a neutron is added, the hydrogen becomes deute...um in place of hydrogen atoms are chemically ident...s. Thus "heavy water", water with molecules that c...cause it disrupts highly sensitive biochemical pro...
(Date:1/8/2009)...ailable in Spanish . , Anti-inflammatory d...processes, but also those that do not. This is why...tory drugs which affect healthy cells. With this a...ue Country is working on analogues of the C1P mole...armaceutical drugs are available: steroids and tho...
(Date:1/8/2009)...ailable in Spanish . , Sludge obtained from...liser for soils, for example or to reduce their ac...ue Country (UPV/EHU) PhD research thesis was to st...n Depuradora de Aguas Residuales - Waste Water Pur...erties of the soil and on the water filtering thro...
Breaking Biology News(10 mins):January GEOLOGY media highlights 2January GEOLOGY media highlights 3January GEOLOGY media highlights 4January GEOLOGY media highlights 5January GEOLOGY media highlights 6January GEOLOGY media highlights 7January GEOLOGY media highlights 8January GEOLOGY media highlights 9January GEOLOGY media highlights 10January GEOLOGY media highlights 11January GEOLOGY media highlights 12Heavy pyridine crystallizes differently 2The quest for specific anti-inflammatory treatment 2The quest for specific anti-inflammatory treatment 3Adding high doses of sludge to neutralize soil acidity not advisable 2Unique role for blood formation gene identified 1098 1Unique role for blood formation gene identified 1098 2AUDIO from Medialink and Pfizer 3A Prescription for Safer Drugs Discussed in Washington 1096 1Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference 1091 1Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference 1091 2Free White Papers Detail Sterility Testing Essentials for Medical Device Pharmaceutical Manufacturers 527 1Free White Papers Detail Sterility Testing Essentials for Medical Device Pharmaceutical Manufacturers 527 2(Date:1/9/2009)...RNewswire/ -- Azur Pharma Limited ("Azur,Pharma")...S. marketing rights,for Niravam(R) (alprazolam or...pa-levodopa orally disintegrating tablets), Kemstr...d Fluxid(TM) (famotidine orally,disintegrating ta...ere not,disclosed. , Niravam, Parcopa and ...
(Date:1/8/2009)...-FirstCall/ -- Orexigen(R) Therapeutics, Inc.,(Na...our Phase 3 trials of its,lead investigational pr...SR)/bupropion SR) met its co-primary and key secon...n body weight, improvements in markers of,cardiov...ng measures. , In this trial, which include...
(Date:1/8/2009)...Newswire/ -- The Nano Science and Technology Ins...onference & Expo 2009 will take place May 3-7,... Houston, Texas. Now in its 12th year, the larges...ted to attract a community of more than 5,000 Nano...ther to promote advanced research and best practic...
(Date:1/8/2009)...irstCall/ -- Allscripts announced today that,Tull...pany, has signed a,definitive agreement to resell...alth Record (EHR) and practice management solution...wscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) , ...forms management solutions,for the health care co...
Breaking Biology Technology:Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 3Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 4Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 5Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 6Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 7NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 2NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 3NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 4Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 2Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 3Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 4Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 5... Last Thursday was a day of interesting juxtaposit...reneurs at eForum 2005, where one of the hot topic...roducts. The thinking was that it,s easier to grow... day, IBM announced that its year over year earnin...f diver because of a slower than expected shift in...
Badger Ventures, a newly forming venture capital firm, hopes to make waves in Madison and gather funding to invest in information technology companies. Also, state Assembly Republicans moved to deny
...Icon Interactive , a technology and marketing firm...king monitor called I! Alert (pronounced I-Bang ...and lets users know the sites, ranking on search e...rs enter the URL and a set of associated keywords ...rms "mortgage" and "loan." The program then displa...
...esearch institutions should create oversight commi...ccording to common guidelines, a panel of experts,...fessors, said on Tuesday in Washington, D.C. , ,"I...ing the generation and research use of human embry...institutions should step forward to develop and im...
Other Biology Technology:IBM takes one direction, Milwaukee entrepreneurs the other 2IBM takes one direction, Milwaukee entrepreneurs the other 3Icon Interactive creates new Web monitoring tool 2...ein Digest Medium (TSB), USP is a highly nutritiou...l laboratory use. Due to the inclusion of both Try...wth of many fastidious organisms without the addit...tates Pharmacopeia standards for use in Microbiolo...
...e Species Tissue Array (MSTA) slides were designed... cells and tissues from multiple species. Tissue ... each MSTA slide which can then be treated as a si...stochemistry, or in situ hybridization. This fo...
The Gene Pulser Xcell eukaryotic system, 100 to 240 V, 50-60 Hz, is used for electroporation of mammalian cells. This system includes the main unit, CE module for exponential (25-3,275 microfarad ran
WinMelt software is used to predict the melting profile of any DNA sequence up to 3,200 bases, which aids in optimizing placement of primers and GC clamps for mutation detection by denaturing gradien
Biology Products: